These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment. Gait MJ; Arzumanov AA; McClorey G; Godfrey C; Betts C; Hammond S; Wood MJA Nucleic Acid Ther; 2019 Feb; 29(1):1-12. PubMed ID: 30307373 [TBL] [Abstract][Full Text] [Related]
16. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy. Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660 [TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold? Guncay A; Yokota T Future Med Chem; 2015; 7(13):1631-5. PubMed ID: 26423833 [No Abstract] [Full Text] [Related]
18. Thiomorpholino oligonucleotides as a robust class of next generation platforms for alternate mRNA splicing. Le BT; Paul S; Jastrzebska K; Langer H; Caruthers MH; Veedu RN Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2207956119. PubMed ID: 36037350 [TBL] [Abstract][Full Text] [Related]
19. Viltolarsen for the treatment of Duchenne muscular dystrophy. Roshmi RR; Yokota T Drugs Today (Barc); 2019 Oct; 55(10):627-639. PubMed ID: 31720560 [TBL] [Abstract][Full Text] [Related]
20. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity. Takada H; Tsuchiya K; Demizu Y Bioconjug Chem; 2022 Jul; 33(7):1311-1318. PubMed ID: 35737901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]